Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             142 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 2.279 ADVERSE EVENTS TO ANTIPARKINSONIAN MEDICATIONS IN PARKINSONIAN AND NON-PARKINSONIAN PATIENTS Perez-Lloret, S.
2012
18 Supplement 2 p. S135-
1 p.
artikel
2 2.3.3 A GENOME-WIDE ANALYSIS IN THE EUROPEAN HD POPULATION Landwehrmeyer, G.B.
2012
18 Supplement 2 p. S83-
1 p.
artikel
3 Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease Yonova-Doing, Ekaterina
2012
18 Supplement 2 p. 567-571
5 p.
artikel
4 1.029 ANALYSIS OF NON-MOTOR SYMPTOMS OF PARKINSON'S DISEASE Meng, L.
2012
18 Supplement 2 p. S17-
1 p.
artikel
5 1.043 ANALYSIS OF SAWLOWING SOUNDS THROUGH SONAR DOPPLER IN PATIENTS WITH PARKINSONS DISEASE Santos, R.S.
2012
18 Supplement 2 p. S20-
1 p.
artikel
6 3.123 A NOVEL BAC α-SYNUCLEIN-GFP TRANSGENIC MOUSE MODEL FOR IMAGING OF α-SYNUCLEIN AGGREGATION Hansen, C.
2012
18 Supplement 2 p. S194-S195
2 p.
artikel
7 Apolipoprotein E gene (APOE) genotype in Wilson’s disease: Impact on clinical presentation Litwin, T.
2012
18 Supplement 2 p. 367-369
3 p.
artikel
8 Apomorphine injections: Predictors of initial common adverse events and long term tolerability Ondo, William G.
2012
18 Supplement 2 p. 619-622
4 p.
artikel
9 Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease Hou, Jyhgong Gabriel
2012
18 Supplement 2 p. 377-381
5 p.
artikel
10 3.017 ASSOCIATION OF MUTATIONS IN THE GLUCOCEREBROSIDASE GENE WITH PARKINSON DISEASE IN A KOREAN POPULATION Kim, Y.J.
2012
18 Supplement 2 p. S173-
1 p.
artikel
11 Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease Prakash, Bhaskaran David
2012
18 Supplement 2 p. 1029-1033
5 p.
artikel
12 3.062 ATAXIN-2 INTERMEDIATE POLYGLUTAMINE EXPANSIONS CONTRIBUTE TO RISK OF ALS AND OF EARLY ONSET HEREDITARY PD Gispert, S.
2012
18 Supplement 2 p. S184-
1 p.
artikel
13 3.072 AUTISM SPECTRUM DISORDER ASSOCIATED WITH LOW BRAIN SEROTONIN AND MUTATIONS IN THE SEROTONIN TRANSPORTER SLC29A 4 AND IN SEROTONIN RELATED GENES Adamsen, D.
2012
18 Supplement 2 p. S187-
1 p.
artikel
14 Autosomal dominant Parkinsonism: its etiologies and differential diagnoses Hattori, Nobutaka
2012
18 Supplement 2 p. S1-S3
3 p.
artikel
15 Autosomal recessive parkinsonism Bonifati, Vincenzo
2012
18 Supplement 2 p. S4-S6
3 p.
artikel
16 3.228 BEHAVIORAL EFFECTS OF A NOVEL DIPEPTIDE MIMETIC OF THE NERVE GROWTH FACTOR IN RODENT MODELS OF PARKINSON'S DISEASE Povarnina, P.
2012
18 Supplement 2 p. S210-
1 p.
artikel
17 Body mass index in Parkinson’s disease: A meta-analysis van der Marck, Marjolein A.
2012
18 Supplement 2 p. 263-267
5 p.
artikel
18 Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease Liu, Jia
2012
18 Supplement 2 p. 140-143
4 p.
artikel
19 3.217 CDNF PROTECTS THE NIGROSTRIATAL DOPAMINE SYSTEM AND PROMOTES RECOVERY AFTER MPTP TREATMENT IN MICE Airavaara, M.
2012
18 Supplement 2 p. S207-S208
2 p.
artikel
20 2.036 CEREBRAL GLUCOSE METABOLISM IN PROGRESSIVE SUPRANUCLEAR PALSY Ma, A.
2012
18 Supplement 2 p. S100-
1 p.
artikel
21 1.17.1 CHOREA AND RELATED DISORDER Zhang, B.
2012
18 Supplement 2 p. S8-
1 p.
artikel
22 Classifying myoclonus: A riddle, wrapped in a mystery, inside an enigma Carr, Jonathan
2012
18 Supplement 2 p. S174-S176
3 p.
artikel
23 Clinical correlates of anterior and lateral flexion of the thoracolumbar spine and dropped head in patients with Parkinson’s disease Kashihara, Kenichi
2012
18 Supplement 2 p. 290-293
4 p.
artikel
24 1.046 CLINICAL CORRELATES OF APATHY IN EARLY PARKINSON DISEASE: THE ANIMO STUDY Cubo, E.
2012
18 Supplement 2 p. S21-
1 p.
artikel
25 Clinical management of pain and fatigue in Parkinson's disease Del Sorbo, Francesca
2012
18 Supplement 2 p. S233-S236
4 p.
artikel
26 1.012 CLINICAL SCENARIO OF PATIENTS WITH PARKINSONISM: A MONGOLIAN STUDY Sosorburam, T.
2012
18 Supplement 2 p. S13-
1 p.
artikel
27 1.205 COEXISTENCE OF ALS/ET/PD AND ALS/ET/MSA IN TWO DIFFERENT FAMILIES He, X.
2012
18 Supplement 2 p. S48-
1 p.
artikel
28 Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease Ben Sassi, Samia
2012
18 Supplement 2 p. 243-246
4 p.
artikel
29 2.113 CONTRAST SENSITIVITY VISUAL ACUITY IS DEFICIENT IN PARKINSON'S DISEASE AND DEGRADES MOTOR PERFORMANCE Swigler, C.
2012
18 Supplement 2 p. S104-S105
2 p.
artikel
30 Cortical control of voluntary saccades in Parkinson's disease and pre-emptive perception Javaid, M.A.
2012
18 Supplement 2 p. S100-S103
4 p.
artikel
31 1.115 DECREASED MOTOR CORTICAL INHIBITION AND INCREASED FACILITATION IN PARKINSON'S DISEASE Ni, Z.
2012
18 Supplement 2 p. S39-
1 p.
artikel
32 3.059 DE NOVO MUTATED ATAXIN-2 INTERMEDIATE-LENGTH POLYGLUTAMINE ASSOCIATED WITH FAMILIAR ALS AND PARKINSONISM/ESSENTIAL TREMOR Laffita, J.
2012
18 Supplement 2 p. S183-
1 p.
artikel
33 3.343 DEREGULATED MIRNA-184 INDUCES CELL CYCLE RE-ENTRY AND APOPTOSIS OF POSTMITOTIC DOPAMINERGIC NEURONS VIA REGULATION OF E2F IN PARKINSON DISEASE Zhang, Z.
2012
18 Supplement 2 p. S229-S230
2 p.
artikel
34 3.260 D-β-HYDROXYBUTYRATE IS NEUROPROTECTIVE IN MOUSE MODELS OF HUNTINGTON'S DISEASE Lim, S.
2012
18 Supplement 2 p. S218-
1 p.
artikel
35 Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: A meta-analysis of published studies Papathanasiou, Nikolaos D.
2012
18 Supplement 2 p. 225-229
5 p.
artikel
36 2.005 DIFFERENT SIGNALS OF MAGNETIC RESONANCE IMAGING AND ULTRASOUND FROM PARKINSONIAN SUBSTANTIA NIGRA AND CONTROL – IS IRON THE CAUSE? Galazka-Friedman, J.
2012
18 Supplement 2 p. S92-
1 p.
artikel
37 Direct costs and survival of medicare beneficiaries with early and advanced parkinson’s disease Kaltenboeck, A.
2012
18 Supplement 2 p. 321-326
6 p.
artikel
38 Dyskinesias in patients with Parkinson's disease: Effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation Yahalom, Gilad
2012
18 Supplement 2 p. 1039-1041
3 p.
artikel
39 2.341 EARLY, POSTOPERATIVE MICROLESION EFFECT AS A PREDICTOR OF SUBTHALAMIC DEEP BRAIN STIMULATION EFFECTIVENESS FOR PARKINSON'S DISEASE Tykocki, T.
2012
18 Supplement 2 p. S151-
1 p.
artikel
40 Editorial Board 2012
18 Supplement 2 p. i-
1 p.
artikel
41 1.325 EFFECT OF LEVETIRACETAM MONOTHERAPY ON EPILEPTIC TODDLERS WITH CEREBRAL PALSY: A OPEN, PROSPECTIVE, SHORT-TERM AND CONTROLLED CLINICAL TRIAL Jia, F.
2012
18 Supplement 2 p. S78-
1 p.
artikel
42 2.022 EFFECT OF PRAMIPEXOLE ON REGIONAL CEREBRAL BLOOD FLOW IN PARKINSON'S DISEASE Hirano, S.
2012
18 Supplement 2 p. S96-
1 p.
artikel
43 2.237 EFFECT OF TETRAHYDROBIOPTERIN AND PHARMACOLOGICAL CHAPERONES ON TYROSINE HYDROXYLASE; CORRECTION OF NEUROTRANSMITTER DEFICIENCIES Ying, M.
2012
18 Supplement 2 p. S124-
1 p.
artikel
44 2.220 EFFECTS OF ENGRAFTED HAIR FOLLICLE STEM CELLS IN ALZHEIMER'S DISEASE RATS Nobakht, M.
2012
18 Supplement 2 p. S119-
1 p.
artikel
45 2.293 EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PARKINSONISM OF MULTIPLE SYSTEM ATROPHY: CLINICAL, ELECTROPHYSIOLOGICAL AND FUNCTIONAL MRI STUDY Wang, H.
2012
18 Supplement 2 p. S139-
1 p.
artikel
46 2.327 EFFICACY OF CHRONIC BILATERAL STN-DBS ON ALTERED EYE-TO-FOOT CO-ORDINATION IN STANDING ADVANCED PARKINSONIAN PATIENTS DURING LARGE GAZE AND WHOLE-BODY REORIENTATIONS Naushahi, M.J.
2012
18 Supplement 2 p. S148-
1 p.
artikel
47 1.319 ELECTRONYSTAGMOGRAPHY FINDINGS IN SPINOCEREBELLAR ATAXIA TYPE 3 AND 2 Santos, R.S.
2012
18 Supplement 2 p. S76-S77
2 p.
artikel
48 Epidemiology and clinical phenomenology for Parkinson's disease with pain and fatigue Wen, Hong-Bo
2012
18 Supplement 2 p. S222-S225
4 p.
artikel
49 2.206 EPIGALLOCAETECHIN GALLATE (EGCG) INHIBITS A-SYNUCLEIN AGGREGATION: A POTENTIAL AGENT FOR PARKINSON DISEASE Zhang, Y.
2012
18 Supplement 2 p. S116-
1 p.
artikel
50 3.073 EPIGENETIC DNA-METHYLATION IN THE CORE ATAXIN-2 GENE PROMOTER: NOVEL PHYSIOLOGICAL AND PATHOLOGICAL IMPLICATIONS Laffita, J.
2012
18 Supplement 2 p. S187-
1 p.
artikel
51 3.358 ESTABLISHMENT OF 2-DE OF CEREBROSPINAL FLUID AND PRIMARY STUDY OF CSF PROTEOME OF PARKINSON'S DISEASE Li, H.
2012
18 Supplement 2 p. S233-
1 p.
artikel
52 3.126 EVALUATION OF DRUGS ACTING ON CB1-A2A RECEPTOR OLIGOMERS IN RAT MODELS OF PARKINSON'S DISEASE Simola, N.
2012
18 Supplement 2 p. S195-
1 p.
artikel
53 2.268 FIRST 2-YEAR, PLACEBO-CONTROLLED STUDY IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS INDICATES SAFINAMIDE MAY BENEFIT PATIENTS WITH MORE SEVERE DYSKINESIA Anand, R.
2012
18 Supplement 2 p. S132-S133
2 p.
artikel
54 1.263 FUNCTIONAL OUTCOME OF DEFEROXAMINE PRIMED HUMAN ADIPOSE DERIVED MESENCHYMAL STEM CELL TRANSPLANTS IN A RAT MODEL OF HUNTINGTON'S DISEASE Edalatmanesh, M.A.
2012
18 Supplement 2 p. S62-S63
2 p.
artikel
55 Genetic mouse models for understanding LRRK2 biology, pathology and pre-clinical application Yue, Zhenyu
2012
18 Supplement 2 p. S180-S182
3 p.
artikel
56 123I-MIBG myocardial scintigraphy for differentiating Parkinson’s disease from other neurodegenerative parkinsonism: A systematic review and meta-analysis Orimo, Satoshi
2012
18 Supplement 2 p. 494-500
7 p.
artikel
57 2.251 IMPACT OF LEVODOPA ON IMPROVING LIMB SYMMETRY DURING WALKING IN PARKINSON DISEASE Jog, M.S.
2012
18 Supplement 2 p. S127-S128
2 p.
artikel
58 Impulse control disorders in Parkinson's disease Vilas, Dolores
2012
18 Supplement 2 p. S80-S84
5 p.
artikel
59 1.101 INFLUENCE OF PATIENTS' EXPECTATIONS ON NON-MOTOR SYMPTOMS AND QUALITY OF LIFE IN PARKINSON'S DISEASE: A MIXED-METHOD STUDY Lenihan, N.
2012
18 Supplement 2 p. S35-
1 p.
artikel
60 3.242 INHIBITION OF MONOAMINE OXIDASE-B BY CURCUMIN AND TETRAHYDROCURCUMIN IN THE MICE MODEL OF PARKINSON'S DISEASE Muthukumaran, S. Sabesan
2012
18 Supplement 2 p. S214-
1 p.
artikel
61 3.034 INTRACELLULAR TRAFFICKING OF A53T MUTANT ALPHA-SYNUCLEIN INVOLVED IN MICROGLIAL PERSISTENT ACTIVATION Wu, Y.-W.
2012
18 Supplement 2 p. S177-
1 p.
artikel
62 1.130 INVERSE RELATIONSHIP BETWEEN THE CONTENTS OF NEUROMELANIN PIGMENT AND THE VESICULAR MONOAMINE TRANSPORTER-2 AMONG SUBSTANTIA NIGRA AND VENTERAL TEGMENTAL AREA Pasbakhsh, P.
2012
18 Supplement 2 p. S42-S43
2 p.
artikel
63 1.308 INVESTIGATION OF THE NEUROFUNCTIONAL SUBSTRATES BEHIND PRESERVED BICYCLING ABILITIES IN PARKINSON'S DISEASE PATIENTS WITH SEVERE GAIT DISTURBANCES Maliia, M.
2012
18 Supplement 2 p. S74-
1 p.
artikel
64 3.328 IN VITRO AND IN VIVO EVALUATION OF COQ10 LOADED POLYMERIC NANOPARTICLES: AN ATTEMPT TO RESCUE THE CELLS FROM OXIDATIVE STRESS Swarnakar, N.K.
2012
18 Supplement 2 p. S226-
1 p.
artikel
65 3.049 LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE PATIENTS CARRYING THE LEUCINE-RICH REPEAT KINASE 2 (LRRK2) G2019S MUTATION Yahalom, G.
2012
18 Supplement 2 p. S181-
1 p.
artikel
66 LINGO-2 polymorphism and the risk of Parkinson’s disease in Taiwan Su, Feng-Chieh
2012
18 Supplement 2 p. 609-611
3 p.
artikel
67 2.039 LONGITUDINAL PET STUDIES OF MICROGLIAL ACTIVATION IN HUNTINGTON'S DISEASE Tai, Y.F.
2012
18 Supplement 2 p. S101-
1 p.
artikel
68 2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE Poewe, W.
2012
18 Supplement 2 p. S131-S132
2 p.
artikel
69 Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study Elmer, Lawrence W.
2012
18 Supplement 2 p. 488-493
6 p.
artikel
70 3.031 LOSS OF PINK1 FUNCTION PROMOTES AUTOPHAGY VIA PP2A DOWNREGULATION IN DOPAMINERGIC CELLS AND A MURINE MODEL Yang, W.
2012
18 Supplement 2 p. S176-S177
2 p.
artikel
71 1.291 LOW FREQUENCY RTMS OVER THE PREMOTOR CORTEX SUPPRESS DYSTONIA AND ABNORMAL CORTICAL EXCITABILITY: A CASE REPORT Kim, Y.-H.
2012
18 Supplement 2 p. S69-S70
2 p.
artikel
72 LRRK2 I2020T mutation is associated with tau pathology Ujiie, Sachiko
2012
18 Supplement 2 p. 819-823
5 p.
artikel
73 3.325 MEASURES DEALING WITH EMERGENCIES FOR PATIENTS WITH INTRACTABLE NEUROLOGICAL DISEASE IN SAGAMIHARA AREA Saruwatari, M.
2012
18 Supplement 2 p. S225-
1 p.
artikel
74 1.077 MEMORY MONITORING AND EPISODIC MEMORY OF PARKINSON'S PATIENTS Lv, X.
2012
18 Supplement 2 p. S29-
1 p.
artikel
75 1.5.3 METABOLIC NETWORKING IN CHINESE PATIENTS WITH PARKINSON'S DISEASE IN VARIOUS HOEHN & YAHR STAGES Wang, J.
2012
18 Supplement 2 p. S3-
1 p.
artikel
76 Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort Wahlqvist, Mark L.
2012
18 Supplement 2 p. 753-758
6 p.
artikel
77 3.349 MIXED LINEAGE KINASE 2 AND HIPPOCALCIN ARE LOCALIZED IN LEWY BODIES OF PARKINSON'S DISEASE Nagao, M.
2012
18 Supplement 2 p. S231-
1 p.
artikel
78 Molecular pathways in sporadic PD Valente, Enza Maria
2012
18 Supplement 2 p. S71-S73
3 p.
artikel
79 Mouse models for LRRK2 Parkinson's disease Xu, Qing
2012
18 Supplement 2 p. S186-S189
4 p.
artikel
80 2.008 MR IMAGING BIOMARKERS FOR DIFFERENTIATION OF PARKINSON DISEASE FROM HEALTHY CONTROLS USING DIFFUSION TENSOR IMAGING ON 3 TESLA MRI Kumari, R.
2012
18 Supplement 2 p. S92-S93
2 p.
artikel
81 3.18.4 MULTIPLE SYSTEM ATROPHY - ADVANCES IN IMAGING Chen, H.
2012
18 Supplement 2 p. S169-
1 p.
artikel
82 3.3.3 MYOCLONUS: CLINICAL PRESENTATION Roze, E.
2012
18 Supplement 2 p. S163-
1 p.
artikel
83 Neurodegeneration and Inflammation in Parkinson's disease Phani, Sudarshan
2012
18 Supplement 2 p. S207-S209
3 p.
artikel
84 1.12.4 NEUROIMAGING IN PARKINSON'S DISEASE Stoessl, A.J.
2012
18 Supplement 2 p. S6-
1 p.
artikel
85 1.222 NEUROLEPTIC MALIGNANT SYNDROME WITH ATYPICAL NEUROLEPTICS AND DOPAMINE MODULATING DRUGS: SEVEN CASE REPORTS Sharms, J.B.
2012
18 Supplement 2 p. S52-
1 p.
artikel
86 2.310 NEUROPSYCHOLOGICAL FINDINGS IN PATIENTS WITH PARKINSON'S DISEASE SUBMITTED TO UNILATERAL ABLATIVE PROCEDURES Heluani, A.
2012
18 Supplement 2 p. S143-S144
2 p.
artikel
87 1.219 NEUROSYPHILIS PRESENTING WITH PARKINSONISM Fan, L.
2012
18 Supplement 2 p. S51-
1 p.
artikel
88 New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism Barbano, Richard L.
2012
18 Supplement 2 p. 737-741
5 p.
artikel
89 1.057 NOCTURNAL DISTURBANCES IN PARKINSON'S DISEASE: A VALIDATION STUDY OF PARKINSON'S DISEASE SLEEP SCALE-2 JAPANESE VERSION Suzuki, K.
2012
18 Supplement 2 p. S24-
1 p.
artikel
90 No evidence of association between the LINGO4 gene and essential tremor in Chinese Han patients Liang, Hui
2012
18 Supplement 2 p. 303-305
3 p.
artikel
91 3.1.1 OVERVIEW OF PRIMARY MONOGENIC DYSTONIA Spatola, M.
2012
18 Supplement 2 p. S161-
1 p.
artikel
92 3.107 PARAQUAT ACTIVATES THE IRE1/ASK1/JNK CASCADE ASSOCIATED WITH APOPTOSIS IN SH-SY5Y CELLS Son, I.
2012
18 Supplement 2 p. S191-
1 p.
artikel
93 3.311 PARKINSON DISEASE AND PAIN: DOPAMINERGIC MODULATION ON THE MECHANICAL HYPERALGESIA IN HEMIPARKINSONIAN RATS Maciel, S.T.
2012
18 Supplement 2 p. S222-
1 p.
artikel
94 Parkinsonism and dropped head: Dystonia, myopathy or both? Savica, Rodolfo
2012
18 Supplement 2 p. 30-34
5 p.
artikel
95 Parkinson's disease: Molecular risk factors Grünblatt, Edna
2012
18 Supplement 2 p. S45-S48
4 p.
artikel
96 PARK2 variability in Polish Parkinson’s disease patients - interaction with mitochondrial haplogroups Gaweda-Walerych, Katarzyna
2012
18 Supplement 2 p. 520-524
5 p.
artikel
97 1.19.2 PD IN EVOLUTION: PRODROME TO DEGENERATION Schapira, A.
2012
18 Supplement 2 p. S9-
1 p.
artikel
98 Personality profile in essential tremor: A case–control study Thenganatt, Mary Ann
2012
18 Supplement 2 p. 1042-1044
3 p.
artikel
99 2.356 POSSIBILITIES AND LIMITS OF REHABILITATION PROGRAM IN PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES Nica, A.S.
2012
18 Supplement 2 p. S155-
1 p.
artikel
100 2.203 PRECLINICAL EVALUATION OF KOM-1962, A POTENT SELECTIVE INHIBITOR OF CATECHOL-O-METHYLTRANSFERASE, AS A NOVEL DRUG CANDIDATE FOR PARKINSON'S DISEASE Wanajo, I.
2012
18 Supplement 2 p. S115-
1 p.
artikel
101 Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience Ross, G. Webster
2012
18 Supplement 2 p. S199-S202
4 p.
artikel
102 Prevalence of oropharyngeal dysphagia in Parkinson’s disease: A meta-analysis Kalf, J.G.
2012
18 Supplement 2 p. 311-315
5 p.
artikel
103 1.246 PROFUSE SIALORRHEA AND HEMIBALLISM IN A CASE OF ANTI N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS Montero, R. Salazar
2012
18 Supplement 2 p. S58-
1 p.
artikel
104 1.260 PROTECTIVE EFFECT OF ROFECOXIB AND NIMESULIDE AGAINST INTRA-STRIATAL QUINOLINIC ACID INDUCED BEHAVIORAL, OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTIONS IN RATS Kalonia, H.
2012
18 Supplement 2 p. S62-
1 p.
artikel
105 2.15.2 PSYCHOGENIC MOVEMENT DISORDERS (2) Kompoliti, K.
2012
18 Supplement 2 p. S88-S89
2 p.
artikel
106 2.15.1 PSYCHOGENIC MOVEMENT DISORDERS (1) Hallett, M.
2012
18 Supplement 2 p. S88-
1 p.
artikel
107 1.087 PSYCHOSIS: ONE OF THE MOST COMMON NON-MOTOR MANIFESTATIONS IN PD Meng, L.
2012
18 Supplement 2 p. S31-
1 p.
artikel
108 Pulsatile or continuous dopaminomimetic strategies in Parkinson's disease Calandrella, Daniela
2012
18 Supplement 2 p. S120-S122
3 p.
artikel
109 2.359 QUALITY OF LIFE SCALE IN PARKINSON'S DISEASE IN RELATION TO AMBULATORY INDEPENDENCY Kwok, C.M.
2012
18 Supplement 2 p. S155-S156
2 p.
artikel
110 Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson’s disease: A meta-analysis Wu, Xi
2012
18 Supplement 2 p. 722-730
9 p.
artikel
111 2.234 RISK FACTORS FOR LEVODOPA-RELATED DYSKINESIAS IN PARKINSON'S DISEASE Zhang, H.
2012
18 Supplement 2 p. S123-
1 p.
artikel
112 1.118 RISKS OF PARKINSON DISEASE IN PATIENTS WITH AUTOIMMUNE DISORDERS: A NATION-WIDE EPIDEMIOLOGICAL STUDY FROM SWEDEN Li, X.
2012
18 Supplement 2 p. S40-
1 p.
artikel
113 Role of genetic polymorphisms of the dopaminergic system in Parkinson’s disease patients with impulse control disorders Vallelunga, Annamaria
2012
18 Supplement 2 p. 397-399
3 p.
artikel
114 Role of Mendelian genes in “sporadic” Parkinson's disease Lesage, Suzanne
2012
18 Supplement 2 p. S66-S70
5 p.
artikel
115 Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease Pontieri, Francesco E.
2012
18 Supplement 2 p. 871-875
5 p.
artikel
116 Serotonergic action on dorsal striatal function Mathur, Brian N.
2012
18 Supplement 2 p. S129-S131
3 p.
artikel
117 SETX gene novel mutations in a non-French Canadian with ataxia-oculomotor apraxia type 2 Ghrooda, Sadik
2012
18 Supplement 2 p. 700-701
2 p.
artikel
118 1.060 SLEEP REGULATORY CENTRES DYSFUNCTION IN PARKINSON'S DISEASE PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS. AN IN VIVO PET STUDY Pavese, N.
2012
18 Supplement 2 p. S24-S25
2 p.
artikel
119 SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population Trotta, Luca
2012
18 Supplement 2 p. 257-262
6 p.
artikel
120 3.214 STRUCTURAL SPECIFICITY OF AKT-MEDIATED NEUROPROTECTION BY OXICAM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AGAINST 1-METHYL-4-PHENYL PYRIDINIUM-INDUCED CELL DEATH Tasaki, Y.
2012
18 Supplement 2 p. S207-
1 p.
artikel
121 3.033 THE AGGREGATED WT-α-SYNUCLEIN AND A53T PROMOTE INFLAMMATION THROUGH ACTIVATION OF NADPH OXIDASE COMPLEX IN BV-2 AND PRIMARY MICROGLIA Kang, W.
2012
18 Supplement 2 p. S177-
1 p.
artikel
122 2.324 THE BILATERAL STN-DBS CAN IMPROVE MOTOR AND NON-MOTOR SYMPTOMS IN MODERATE AND ADVANCED PD PATIENTS: A TWO-YEAR FOLLOW-UP STUDY Fu, X.
2012
18 Supplement 2 p. S147-
1 p.
artikel
123 3.13.3 THE CHINA EXPERIENCE Chan, P.
2012
18 Supplement 2 p. S166-
1 p.
artikel
124 3.140 THE CONTRIBUTION OF THE MYD88-DEPENDENT PATHWAY IN ANIMAL MODELS OF PARKINSONISM Drouin-Ouellet, J.
2012
18 Supplement 2 p. S199-
1 p.
artikel
125 3.360 THE CONTRIBUTION OF THE SELF POLYQ LOAD [SOMATIC MOSAICISM] IN THE CNS TO THE ONSET, DURATION AND PROGRESSION OF SCA2 Laffita, J.
2012
18 Supplement 2 p. S234-
1 p.
artikel
126 1.294 THE CURATIVE EFFECT EVALUATIONS FOR BOTULINUM TOXIN-A TREATMENT OF SPASMODIC TORTICOLLIS WITH THE GUIDANCE OF ‘SENSORY TRICK’ COMBINE WITH EMG Ge, H.-M.
2012
18 Supplement 2 p. S70-
1 p.
artikel
127 The effects of gait impairment with and without freezing of gait in Parkinson’s disease Josiah, Anne F.
2012
18 Supplement 2 p. 239-242
4 p.
artikel
128 2.141 THE 18[F]-FDG PET STUDY ON THE IDIOPATHIC PARKINSON'S DISEASE AND SEVERAL PARKINSONIAN-PLUS SYNDROME Zhao, P.
2012
18 Supplement 2 p. S112-
1 p.
artikel
129 2.10.1 THE IRON STORY Riederer, P.F.
2012
18 Supplement 2 p. S85-
1 p.
artikel
130 3.257 THE NEUROPROTECTIVE EFFECTS OF JNK3-N-TAT THROUGH INHIBITING THE ACTIVATION OF JNK3 AND PROTECTING MITOCHODRIA Pan, J.
2012
18 Supplement 2 p. S217-
1 p.
artikel
131 1.074 THE PATTERN OF CORTICAL ATROPHY IN PARKINSON'S DISEASE WITH MILD COGNITIVE IMPAIRMENT ACCORDING TO THE TIMING OF COGNITIVE DYSFUNCTION Lee, P.H.
2012
18 Supplement 2 p. S28-
1 p.
artikel
132 1.236 THE SPECTRUM OF MYOCLONUS IN BLACK AFRICAN PATIENTS - A RETROSPECTIVE ANALYSIS Wynand, L.M.
2012
18 Supplement 2 p. S55-
1 p.
artikel
133 1.132 TYROSINE HYDROXYLASE INTERACTING WITH PHOSPHOLIPID MEMBRANES: A MOLECULAR DYNAMICS STUDY Skjevik, Å.A.
2012
18 Supplement 2 p. S43-
1 p.
artikel
134 3.048 UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING LEUCINE-RICH REPEAT KINASE 2 (LRRK2)-RELATED PARKINSON'S DISEASE (PD) Liu, H.
2012
18 Supplement 2 p. S180-S181
2 p.
artikel
135 3.075 UNEXPANDED AND INTERMEDIATE POLYMORPHISMS AT SCA2 LOCUS (ATXN2) IN THE CUBAN POPULATION: EVIDENCES ABOUT THE ORIGIN OF EXPANDED ALLELES Laffita, J.
2012
18 Supplement 2 p. S188-
1 p.
artikel
136 Upcoming treatments in Parkinson's disease, including gene therapy Rodnitzky, Robert L
2012
18 Supplement 2 p. S37-S40
4 p.
artikel
137 3.157 UPREGULATION OF ETK AFTER RAT TRAUMATIC BRAIN INJURY Chen, K.-Y.
2012
18 Supplement 2 p. S203-
1 p.
artikel
138 Vaccination for Parkinson's disease Schneeberger, A.
2012
18 Supplement 2 p. S11-S13
3 p.
artikel
139 What are the issues facing Parkinson's disease patients at ten years of disease and beyond?: Data from the NPF-QII study Hassan, Anhar
2012
18 Supplement 2 p. S10-S14
5 p.
artikel
140 3.12.1 WHAT ARE THE PITFALLS OF CLINICAL TRIALS IN PARKINSON'S DISEASE? Korczyn, A.D.
2012
18 Supplement 2 p. S166-
1 p.
artikel
141 2.8.1 WHAT REALLY MATTERS IN EARLY AND ADVANCED PARKINSON'S DISEASE Wolters, E.C.
2012
18 Supplement 2 p. S85-
1 p.
artikel
142 1.277 WILSON'S DISEASE IN THE SOUTH OF BRAZIL: A 40 YEARS FOLLOW-UP STUDY Teive, H.A.G.
2012
18 Supplement 2 p. S66-
1 p.
artikel
                             142 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland